Table of Contents
TABLE OF CONTENTS
LIST OF FIGURES
LIST OF CHARTS
EXECUTIVE SUMMARY
- 1.1 EUROPEAN MARKET FOR INTERVENTIONAL CARDIOLOGY DEVICES
- 1.2 TREND ANALYSIS BY COUNTRY
- 1.3 PROCEDURE NUMBERS
- 1.4 COUNTRY PROFILE
- 1.4.1 Population
- 1.4.2 GDP per Capita
- 1.4.3 PCI and DES Penetration Rates
- 1.4.4 Price Index
- 1.5 CORONARY STENTS
- 1.6 PTCA BALLOONS
- 1.7 INTERVENTIONAL CATHETERS
- 1.8 INTERVENTIONAL GUIDEWIRES
- 1.9 INTROD UCER SHEATHS
- 1.10 IVUS CATHETERS
- 1.11 BRACHY THERAPY CATHETERS
- 1.12 EMBOLIC PROTECTION DEVICES
- 1.13 DIAGNOSTIC CATHETERS AND GUIDEWIRES
- 1.14 COMPETITIVE ANALYSIS
RESEARCH METHODOLOGY
- 2.1 RESEARCH SCOPE
- 2.2 IDATAS 9 STEP METHODOLOGY
- Step 1 : Project Initiation & Team Selection
- Step 2: Prepare Data Systems and Perform Secondary Research
- Step 3: Preparation for Interviews & Survey design
- Step 4: Performing Primary Research
- Step 5: Research Analysis: Establishing Baseline Estimates
- Step 6: Market Forecasting
- Step 7: Identify Strategic Opportunities
- Step 8: Final Review and Market Release
- Step 9: Customer Feedback and Market Monitoring
EUROPEAN MARKET FOR INTERVENTIONAL CARDIOLOGY DEVICES
- 3.1 INTRODUCTION
- 3.2 CURRENCY EXCHANGE RATE
- 3.3 OVERVIEW OF THE MARKET
- 3.4 TREND ANALYSIS BY COUNTRY
- 3.5 MARKET DRIVERS
- 3.5.1 Changes in the Healthcare System
- 3.5.2 DESMarket
- 3.5.3 Demographics
- 3.6 MARKET LIMITERS
- 3.6.1 Budget Constraints
- 3.6.2 Price Erosion
- 3.6.3 Late-Stent Thrombosis
- 3.7 COMPETITIVE ANALYSIS
- 3.7.1 Market Concentration
- 3.8 MERGERS AND ACQUISITIONS
- 3.8.1 Boston Scientific Acquires Guidant
- 3.8.2 Abbott Laboratories Acquires Guidant' s Interventional Cardiology Division
- 3.8.3 Johnson & Johnson Agrees to Acquire Conor Medsystems
- 3.8.4 Future Acquisitions
- 3.9 LITIGATION ISSUES
- 3.10 EMERGING MARKETS
- 3.11 POTENTIAL MARKET: VULNERABLE PLAQUE
- 3.12 MARKET HIGHLIGHTS
- 3.12.1 Abbott Laboratories Introduces Xience
- 3.12.2 Xtent Prepares to Enter the European Market
- 3.12.3 B. Braun Releases New DES
PROCEDURE NUMBERS
- 4.1 TOTAL PROCEDURE NUMBERS
- 4.2 GERMANY
- 4.3 FRANCE
- 4.4 ITALY
- 4.5 UNITED KINGDOM
- 4.6 SPAIN
- 4.7 BENELUX
- 4.7.1 Belgium
- 4.7.2 Netherlands
- 4.8 SCANDINAVIA
- 4.9 SWITZERLAND
- 4.10 AUSTRIA
- 4.11 PORTUGAL
- 4.12 POLAND
COUNTRY PROFILES
- 5.1 INTRODUCTION
- 5.1.1 Population
- 5.1.2 GDP per Capita
- 5.1.3 PCI and DES Penetration Rates
- 5.1.4 Price Index
- 5.2 GERMANY
- 5.3 FRANCE
- 5.4 ITALY
- 5.5 UNITED KINGDOM
- 5.6 SPAN
- 5.7 BENELUX
- 5.8 SCANDINAVIA
- 5.9 SWITZERLAND
- 5.10 AUSTRIA
- 5.11 PORTUGAL
- 5.12 POLAND
BARE-METAL AND DRUG-ELUTNG STENTS
- 6.1 INTRODUCTION
- 6.2 OVERVIEW OF THE MARKET
- 6.2.1 Market Analysis and Forecast
- 6.2.2 Bare-Metal versus Drug-Eluting Stents
- 6.2.3 Bare-Metal Stent Market
- 6.2.4 Drug-Eluting Stent Market
- 6.2.5 Market Drivers
- 6.2.6 Market Limiters
- 6.3 GERMANY
- 6.3.1 Bare-Metal Stent Market
- 6.3.2 Drug-Eluting Stent Market
- 6.4 FRANCE
- 6.4.1 Bare-Metal Stent Market
- 6.4.2 Drug-Eluting Stent Market
- 6.5 ITALY
- 6.5.1 Bare-Metal Stent Market
- 6.5.2 Drug-Eluting Stent Market
- 6.6 UNITED KINGDOM
- 6.6.1 Bare-Metal Stent Market
- 6.6.2 Drug-Eluting Stent Market
- 6.7 SPAIN
- 6.7.1 Bare-Metal Stent Market
- 6.7.2 Drug-Eluting Stent Market
- 6.8 BENELUX
- 6.8.1 Bare-Metal Stent Market
- 6.8.2 Drug-Eluting Stent Market
- 6.9 SCANDINAVIA
- 6.9.1 Bare-Metal Stent Market
- 6.9.2 Drug-Eluting Stent Market
- 6.10 SWITZERLAND
- 6.10.1 Bare-Metal Stent Market
- 6.10.2 Drug-Eluting Stent Market
- 6.11 AUSTRIA
- 6.11.1 Bare-Metal Stent Market
- 6.11.2 Drug-Eluting Stent Market
- 6.12 PORTUGAL
- 6.12.1 Bare-Metal Stent Market
- 6.12.2 Drug-Eluting Stent Market
- 6.13 POLAND
- Bare-Metal Stent Market
- 6.13.2 Drug-Eluting Stent Market
PTCA BALLOON CATHETERS
- 7.1 INTRODUCTION
- 7.2 OVERVIEW OF THE MARKET
- 7.2.1 Market Analysis and Forecast
- 7.2.2 Market Drivers
- 7.2.3 Market Limiters
- 7.2.4 Competitive Analysis
- 7.3 GERMANY
- 7.3.1 Market Analysis and Forecast
- 7.3.2 Competitive Analysis
- 7.4 FRANCE
- 7.4.1 Market Analysis and Forecast
- 7.4.2 Competitive Analysis
- 7.5 ITALY
- 7.5.1 Market Analysis and Forecast
- 7.5.2 Competitive Analysis
- 7.6 UNITED KINGDOM
- 7.6.1 Market Analysis and Forecast
- 7.6.2 Competitive Analysis
- 7.7 SPAIN
- 7.7.1 Market Analysis and Forecast
- 7.7.2 Competitive Analysis
- 7.8 BENELUX
- 7.8.1 Market Analysis and Forecast
- 7.8.2 Competitive Analysis
- 7.9 SCANDINAVIA
- 7.9.1 Market Analysis and Forecast
- 7.9.2 Competitive Analysis
- 7.10 SWITZERLAND
- 7.10.1 Market Analysis and Forecast
- 7.10.2 Competitive Analysis
- 7.11 AUSTRIA
- 7.11.1 Market Analysis and Forecast
- 7.11.2 Competitive Analysis
- 7.12 PORTUGAL
- 7.12.1 Market Analysis and Forecast
- 7.12.2 Competitive Analysis
- 7.13 POLAND
- 7.13.1 Market Analysis and Forecast
- 7.13.2 Competitive Analysis
INTERVENTIONAL CATHETERS
- 8.1 INTRODUCTION
- 8.2 OVERVIEW OF THE MARKET
- 8.2.1 Market Analysis and Forecast
- 8.2.2 Market Drivers
- 8.2.3 Market Limiters
- 8.2.4 Competitive Analysis
- 8.3 GERMANY
- 8.3.1 Market Analysis and Forecast
- 8.3.2 Competitive Analysis
- 8.4 FRANCE
- 8.4.1 Market Analysis and Forecast
- 8.4.2 Competitive Analysis
- 8.5 ITALY
- 8.5.1 Market Analysis and Forecast
- 8.5.2 Competitive Analysis
- 8.6 UNITED KINGDOM
- 8.6.1 Market Analysis and Forecast
- 8.6.2 Competitive Analysis
- 8.7 SPAIN
- 8.7.1 Market Analysis and Forecast
- 8.7.2 Competitive Analysis
- 8.8 BENELUX
- 8.8.1 Market Analysis and Forecast
- 8.8.2 Competitive Analysis
- 8.9 SCANDINAVIA
- 8.9.1 Market Analysis and Forecast
- 8.9.2 Competitive Analysis
- 8.10 SWITZERLAND
- 8.10.1 Market Analysis and Forecast
- 8.10.2 Competitive Analysis
- 8.11 AUSTRIA
- 8.11.1 Market Analysis and Forecast
- 8.11.2 Competitive Analysis
- 8.12 PORTUGAL
- 8.12.1 Market Analysis and Forecast
- 8.12.2 Competitive Analysis
- 8.13 POLAND
- 8.13.1 Market Analysis and Forecast
- 8.13.2 Competitive Analysis
INTERVENTIONAL GUIDEWIRES
- 9.1 INTRODUCTION
- 9.2 OVERVIEW OF THE MARKET
- 9.2.1 Market Analysis and Forecast
- 9.2.2 Market Drivers
- 9.2.3 Market Limiters
- 9.2.4 Competitive Analysis
- 9.3 GERMANY
- 9.3.1 Market Analysis and Forecast
- 9.3.2 Competitive Analysis
- 9.4 FRANCE
- 9.4.1 Market Analysis and Forecast
- 9.4.2 Competitive Analysis
- 9.5 ITALY
- 9.5.1 Market Analysis and Forecast
- 9.5.2 Competitive Analysis
- 9.6 UNITED KINGDOM
- 9.6.1 Market Analysis and Forecast
- 9.6.2 Competitive Analysis
- 9.7 SPAIN
- 9.7.1 Market Analysis and Forecast
- 9.7.2 Competitive Analysis
- 9.8 BENELUX
- 9.8.1 Market Analysis and Forecast
- 9.8.2 Competitive Analysis
- 9.9 SCANDINAVIA
- 9.9.1 Market Analysis and Forecast
- 9.9.2 Competitive Analysis
- 9.10 SWITZERLAND
- 9.10.1 Market Analysis and Forecast
- 9.10.2 Competitive Analysis
- 9.11 AUSTRIA
- 9.11.1 Market Analysis and Forecast
- 9.11.2 Competitive Analysis
- 9.12 PORTUGAL
- 9.12.1 Market Analysis and Forecast
- 9.12.2 Competitive Analysis
- 9.13 POLAND
- 9.13.1 Market Analysis and Forecast
- 9.13.2 Competitive Analysis
INTRODUCER SHEATHS
- 10.1 INTRODUCTION
- 10.2 OVERVIEW OF THE MARKET
- 10.2.1 Market Analysis and Forecast
- 10.2.2 Market by Country
- 10.2.3 Femoral Market
- 10.2.4 Transradial/Brachial Market
- 10.3 MARKET DRIVERS AND LIMITERS
- 10.3.1 Market Drivers
- 10.3.2 Market Limiters
- 10.4 COMPETITIVE ANALYSIS
IVUS CATHETERS
- 11.1 INTRODUCTION
- 11.2 OVERVIEW OF THE MARKET
- 11.2.1 Market Analysis and Forecast
- 11.2.2 Market by Country
- 11.3 MARKET DRIVERS AND LIMITERS
- 11.3.1 Market Drivers
- 11.3.2 Market Limiters
- 11.4 COMPETITIVE ANALYSIS
BRACHY THERAPY CATHETERS
- 12.1 INTRODUCTION
- 12.2 OVERVIEW OF THE MARKET
- 12.2.1 Market Analysis and Forecast
- 12.2.2 Market by Country
- 12.3 MARKET DRIVERS AND LIMITERS
- 12.3.1 Market Drivers
- 12.3.2 Market Limiters
- 12.4 COMPETITIVE ANALYSIS
EMBOLIC PROTECTION DEVICES
- 13.1 INTRODUCTION
- 13.1.1 Application
- 13.1.2 Protection Mechanism
- 13.2 OVERVIEW OF THE MARKET
- 13.2.1 Market Analysis and Forecast
- 13.2.2 Market by Country
- 13.3 MARKET DRIVERS AND LIMITERS
- 13.3.1 Market Drivers
- 13.3.2 Market Limiters
- 13.4 COMPETITIVE ANALYSIS
DIAGNOSTIC CATHETERS AND GUIDEWIRES
- 14.1 INTRODUCTION
- 14.1.1 Diagnostic Procedures: Angiographies
- 14.2 OVERVIEW OF THE MARKET
- 14.2.1 Market Analysis and Forecast
- 14.2.2 Market by Country
- 14.3 DIAGNOSTIC CATHETERS
- 14.3.1 Market Analysis and Forecast
- 14.4 DIAGNOSTIC GUIDEWIRES
- 14.4.1 Market Analysis and Forecast
- 14.5 MARKET DRIVERS AND LIMITERS
- 14.5.1 Market Drivers
- 14.5.2 Market Limiters
- 14.6 COMPETITIVE ANALYSIS
VULNERABLE PLAQUE DEVICES
- 15.1 INTRODUCTION
- 15.2 TARGET POPULATION
- 15.3 POTENTIAL MARKET: BEST-CASE SCENARIO
- 15.4 SCREENING MARKET
- 15.4.1 Market Analysis and Forecast: Best-Case Scenario
- 15.5 INTERVENTIONAL MARKET
- 15.5.1 Market Analysis and Forecast: Best-Case Scenario
- 15.6 TOTAL REVENUE PROBABILITY : SCREENING & INTERVENTIONAL MARKETS
- 15.7 COMPETITIVE ANALYSIS
- 15.7.1 InfraRedX
- 15.7.2 Volcano Therapeutics
- 15.7.3 Bristol-Myers Squibb
- 15.7.4 Medeikon
- 15.7.5 Cryocath
- 15.7.6 Miravant Technologies
- 15.7.7 Boston Scientific
- 15.7.8 Abbott Laboratories
- 15.7.9 Cordis
- 15.7.10 Medtronic
ABBREVIATIONS
LIST OF FIGURES
- Figure 1-1 Market Drivers and Limiters, European Market for PTCA Balloon
Catheters, 2006
- Figure 3-1 Exchange Rate betw een European Currencies and the U.S. Dollar
(US$), 2006
- Figure 3-2 European Market for Interventional Cardiology, Segmented by
Device Type, 2003 - 2013(€)
- Figure 3-3 European Market for Interventional Cardiology, Segmented by
Device Type, 2003 - 2013(US$)
- Figure 3-4 European Market for Interventional Cardiology, Segmented by
Country, 2003 - 2013(€)
- Figure 3-5 European Market for Interventional Cardiology, Segmented by
Country, 2003 - 2013(US$)
- Figure 3-6 Market Drivers, European Market for Interventional Cardiology,
2006
- Figure 3-7 Market Limiters, European Market for Interventional Cardiology
, 2006
- Figure 3-8 Leading Competitors, European Market for Interventional
Cardiology, 2006
- Figure 3-9 Market Concentration based on the Herfindahl Index, European
Market for Interventional Cardiology, 2003 - 2013
- Figure 4-1 Angioplasty Procedures, European Market for Interventional
Cardiology, 2003 - 2013
- Figure 4-2 Angiography Procedures, European Market for Interventional
Cardiology, 2003 - 2013
- Figure 4-3 Angioplasty and Angiography Procedures, German Market for
Interventional Cardiology, 2003 - 2013
- Figure 4-4 Angioplasty and Angiography Procedures, French Market for
Interventional Cardiology, 2003 - 2013
- Figure 4-5 Angioplasty and Angiography Procedures, Italian Market for
Interventional Cardiology, 2003 - 2013
- Figure 4-6 Angioplasty and Angiography Procedures, U.K. Market for
Interventional Cardiology, 2003 - 2013
- Figure 4-7 Angioplasty and Angiography Procedures, Spanish Market for
Interventional Cardiology, 2003 - 2013
- Figure 4-8 Angioplasty and Angiography Procedures, Beneluxian Market for
Interventional Cardiology, 2003 - 2013
- Figure 4-9 Angioplasty and Angiography Procedures, Belgium Market for
Interventional Cardiology, 2003 - 2013
- Figure 4-10 Angioplasty and Angiography Procedures, Dutch Market for
Interventional Cardiology, 2003 - 2013
- Figure 4-11 Angioplasty and Angiography Procedures, Scandinavian Market
for Interventional Cardiology, 2003 - 2013
- Figure 4-12 Angioplasty and Angiography Procedures, Swiss Market for
Interventional Cardiology, 2003 - 2013
- Figure 4-13 Angioplasty and Angiography Procedures, Austrian Market for
Interventional Cardiology, 2003 - 2013
- Figure 4-14 Angioplasty and Angiography Procedures, Portuguese Market for
Interventional Cardiology, 2003 - 2013
- Figure 4-15 Angioplasty and Angiography Procedures, Polish Market for
Interventional Cardiology, 2003 - 2013
- Figure 5-1 Country Indicators, 2006
- Figure 6-1 European Market for Coronary Stents by Type, 2003 - 2013(€)
- Figure 6-2 European Market for Coronary Stents by Type, 2003 - 2013(US$)
- Figure 6-3 European Market for Coronary Stents by Country, 2003 -
2013(€)
- Figure 6-4 European Market for Coronary Stents by Country, 2003 - 2013(US$)
- Figure 6-5 Penetration Rate for Coronary Stents by Type, Units Sold, 2003
- 2013
- Figure 6-6 European Market for Bare-Metal Stents by Country, Stents by
Country, 2003 - 2013(€)
- Figure 6-7 European Market for Bare-Metal Stents by Country, 2003 - 2013
(US$)
- Figure 6-8 Leading Competitors, European Market for Bare-Metal Stents, 2006
- Figure 6-9 European Market for Drug-Eluting Stents by Country, 2003 -
2013(€)
- Figure 6-10 European Market for Drug-Eluting Stents by Country, 2003 -
2013(US$)
- Figure 6-11 Leading Competitors, European Market for Drug-Eluting Stents,
2006
- Figure 6-12 Market Drivers and Limiters, European Market for Coronary
Stents, 2006
- Figure 6-13 German Market for Coronary Stents, Units per PCI Procedure,
2003 - 2013
- Figure 6-14 German Market for Coronary Stents, 2003 - 2013
- Figure 6-15 German Market for Coronary Stents by Type, 2003 - 2013(US$)
- Figure 6-16 German Market for Bare-Metal Stents, 2003 - 2013(€)
- Figure 6-17 German Market for Bare-Metal Stents, 2003 - 2013(US$)
- Figure 6-18 Leading Competitors, German Market for Bare-Metal Stents, 2006
- Figure 6-19 German Market for Drug-Eluting-Stents, 2003 - 2013(€)
- Figure 6-20 German Market for Drug-Eluting-Stents, 2003 - 2013(US$)
- Figure 6-21 Leading Competitors, German Market for Drug-Eluting Stents,
2006
- Figure 6-22 French Market for Coronary Stents, Units per PCI Procedure,
2003 - 2013
- Figure 6-23 French Market for Coronary Stents by Type, 2003 - 2013 (€)
- Figure 6-24 French Market for Coronary Stents by Type, 2003 - 2013(US$)
- Figure 6-25 French Market for Coronary Stents, 2003 - 2013(US$)
- Figure 6-26 French Market for Bare-Metal Stents, 2003 - 2013(US$)
- Figure 6-27 Leading Competitors, French Market for Bare-Metal Stents, 2006
- Figure 6-28 French Market for Drug-Eluting-Stents, , 2003 - 2013(€)
- Figure 6-29 French Market for Drug-Eluting Stents, , 2003 - 2013(US$)
- Figure 6-30 Leading Competitors, French Market for Drug-Eluting Stents,
2006
- Figure 6-31 Italian Market for Coronary Stents, Units per PCI Procedure,
2003 - 2013
- Figure 6-32 Italian Market for Coronary Stents by Type, 2003 - 2013(€)
- Figure 6-33 Italian Market for Coronary Stents by Type, 2003 - 2013(US$)
- Figure 6-34 Italian Market for Bare-Metal Stents, 2003 - 2013 (€)
- Figure 6-35 Italian Market for Bare-Metal Stents, 2003 - 2013 (US$)
- Figure 6-36 Leading Competitors, Italian Market for Bare-Metal Stents, 2006
- Figure 6-37 Italian Market for Drug-Eluting-Stents, 2006
- Figure 6-38 Italian Market for Drug-Eluting Stents, 2003 - 2013(US$)
- Figure 6-39 Leading Competitors, Italian Market for Drug-Eluting Stents,
2006
- Figure 6-40 U.K. Market for Coronary Stents by Type, 2003 - 2013
- Figure 6-41 U.K. Market for Coronary Stents by Type, 2003 - 2013 (€)
- Figure 6-42 U.K. Market for Coronary Stents by Type, 2003 - 2013(US$)
- Figure 6-43 U.K. Market for Coronary Stents by Type, 2003 - 2013(£)
- Figure 6-44 U.K. Market for Bare-Metal Stents, 2003 - 2013(€)
- Figure 6-45 U.K. Market for Bare-Metal Stents, 2003 - 2013(US$)
- Figure 6-46 U.K. Market for Bare-Metal Stents, 2003-2013(£)
- Figure 6-47 Leading Competitors, U.K. Market for Bare-Metal Stents, 2006
- Figure 6-48 U.K. Market for Drug-Eluting-Stents, 2003 - 2013(€)
- Figure 6-49 U.K. Market for Drug-Eluting-Stents, 2003 - 2013(US$)
- Figure 6-50 U.K. Market for Drug-Eluting-Stents, 2003 - 2013(£)
- Figure 6-51 Leading Competitors, U.K. Market for Drug-Eluting Stents, 2006
- Figure 6-52 Spanish Market for Coronary Stents, Units per PCI Procedure,
2003 - 2013
- Figure 6-53 Spanish Market for Coronary Stents by Type, 2003 - 2013(€)
- Figure 6-54 Spanish Market for Coronary Stents by Type, 2003 - 2013(US$)
- Figure 6-55 Spanish Market for Bare-Metal Stents, 2003 - 2013(€)
- Figure 6-56 Spanish Market for Bare-Metal Stents, 2003 - 2013 (US$)
- Figure 6-57 Leading Competitors, Spanish Market for Bare-Metal Stents, 2006
- Figure 6-58 Spanish Market for Drug-Eluting-Stents, 2003 - 2013(€)
- Figure 6-59 Spanish Market for Drug-Eluting-Stents, 2003 - 2013(US$)
- Figure 6-60 Leading Competitors, Spanish Market for Drug-Eluting Stents,
2006
- Figure 6-61 Beneluxian Market for Coronary Stents, Units per PCI
Procedure, 2003 - 2013
- Figure 6-62 Belgian Market for Coronary Stents, Units per PCI Procedure,
2013 - 2013
- Figure 6-63 Dutch Market for Coronary Stents, Units per PCI Procedure,
2013 - 2013
- Figure 6-64 Beneluxian Market for Coronary Stents by Type, 2003 - 2013
(€)
- Figure 6-65 Beneluxian Market for Coronary Stents by Type, 2003 - 2013
(US$)
- Figure 6-66 Beneluxian Market for Bare-Metal Stents, 2003 - 2013(€)
- Figure 6-67 Beneluxian Market for Bare-Metal Stents, 2003 - 2013(US$)
- Figure 6-70 Dutch Market for Bare-Metal Stents, 2003 - 2013(€)
- Figure 6-71 Dutch Market for Bare-Metal Stents, 2003 - 2013 (US$)
- Figure 6-72 Leading Competitors, Beneluxian Market for Bare-Metal Stents,
2006
- Figure 6-73 Beneluxian Market for Drug-Eluting-Stents, 2003 - 2013(€)
- Figure 6-74 Beneluxian Market for Drug-Eluting-Stents, 2003 - 2013(US$)
- Figure 6-79 Leading Competitors, Beneluxian Market for Drug-Eluting
Stents, 2006
- Figure 6-80 Scandinavian Market for Coronary Stents, Units per PCI
Procedure, 2003 - 2013
- Figure 6-83 Scandinavian Market for Coronary Stents, Units per PCI
Procedure, 2003 - 2013
- Figure 6-84 Scandinavian for Bare-Metal Stents, 2003 - 2013 (US$), 2003 -
2013 (US$)
- Figure 6-85 Leading Competitors, Scandinavian Market for Bare-Metal
Stents, 2006
- Figure 6-86 Scandinavian Market for Drug-Eluting-Stents, 2003 - 2013(US$)
- Figure 6-87 Scandinavian Market for Drug-Eluting Stents, 2006
- Figure 6-88 Leading Competitors, Scandinavian Market for Drug-Eluting
Stents, 2006
- Figure 6-89 Swiss Market for Coronary Stents, Units per PCI Procedure,
2003 - 2013
- Figure 6-91 Swiss Market for Coronary Swiss Market for Coronary Stents by
Type, 2003 - 2013(US$)
- Figure 6-92 Swiss Market for Coronary Stents by Type, 2003 - 2013
- Figure 6-93 Swiss Market for Bare-Metal Stents, 2003 - 2013 (US$)
- Figure 6-94 Swiss Market for Bare-Metal Stents, 2003 - 2013 (€)
- Figure 6-95 Swiss Market for Bare-Metal Stents, 2003 - 2013 (US$)
- Figure 6-96 Leading Competitors, Swiss Market for Bare-Metal Stents, 2006
- Figure 6-97 Leading Competitors, Swiss Market for Drug-Eluting Stents,
2003 - 2013 (€)
- Figure 6-98 Leading Competitors, Swiss Market for Drug-Eluting Stents,
2003 - 2013 (US$)
- Figure 6-99 Leading Competitors, Swiss Market for Bare-Metal Stents, 2003
- 2013 (SFr.)
- Figure 6-100 Leading Competitors, Swiss Market for Drug-Eluting Stents,
2006
- Figure 6-101 Austrian Market for Coronary Stents, Units per PCI Procedure,
2003 - 2013
- Figure 6-102 Austrian Market for Coronary by Type, 2003 - 2013(€)
- Figure 6-103 Austrian Market for Coronary Stents by Type, 2003 - 2013 (US$)
- Figure 6-104 Austrian Market for Bare-Metal Stents, 2003 - 2013(€)
- Figure 6-105 Austrian Market for Bare-Metal Stents, 2003 - 2013(US$)
- Figure 6-106 Leading Competitors, Austrian Market for Bare-Metal Stents,
2006
- Figure 6-107 Austrian Market for Drug-Eluting Stents, 2003 - 2013 (€)
- Figure 6-108 Austrian Market for Drug-Eluting Stents, 2003 - 2013 (US$)
- Figure 6-109 Leading Competitors, Austrian Market for Drug-Eluting Stents,
2006
- Figure 6-110 Portuguese Market for Coronary Stents, Units per PCI
Procedure, 2003 - 2013
- Figure 6-113 Portuguese Market for Bare-Metal Stents, 2003 - 2013(€)
- Figure 6-114 Portuguese Market for Bare-Metal Stents, 2003 - 2013(US$)
- Figure 6-115 Leading Competitors, Portuguese Market for Bare-Metal Stents,
2006
- Figure 6-118 Leading Competitors, Portuguese Market for Drug-Eluting
Stents, 2006
- Figure 6-119 Polish Market for Coronary Stents, Units per PCI Procedure,
2003 - 2013
- Figure 6-120 Polish Market for Coronary Stents, Units per PCI Procedure,
2003 - 2013 (€)
- Figure 6-121 Polish Market for Coronary Stents by Type, 2003 - 2013 (US$)
- Figure 6-122 Polish Market for Coronary Stents, by Type, 2003 - 2013
- Figure 6-123 Polish Market for Bare-Metal Stents, 2003 - 2013(€)
- Figure 6-124 Polish Market for Bare-Metal Stents, 2003 - 2013(US$)
- Figure 6-125 Polish Market for Bare-Metal Stents, 2003 - 2013(z1)
- Figure 6-126 Leading Competitors, Polish Market for Bare-Metal Stents, 2006
- Figure 6-127 Polish Market for Drug-Eluting-Stents, 2003 - 2013(€)
- Figure 6-128 Polish Market for Drug-Eluting-Stents, 2003 - 2013(US$)
- Figure 6-129 Polish Market for Drug-Eluting-Stents, 2003 - 2013(US$)
- Figure 6-130 Leading Competitors, Polish Market for Drug-Eluting Stents,
2006
- Figure 7-1 European Market for PTCA Ballooon Catheters, 2003 - 2013(€)
- Figure 7-2 European Market for PTCA Ballooon Catheters, 2003 - 2013(US$)
- Figure 7-3 Market Drivers and Limiters, European Market for PTCA Balloon
Catheters, 2006
- Figure 7-4 Leading Competitors, European Market for PTCA Balloon
Catheters, 2006
- Figure 7-5 Units Sold, German Market for PTCA Balloon Catheters, 2003 -
2013
- Figure 7-6 German Market for PTCA Balloon Catheters, 2003 - 2013(€)
- Figure 7-7 German Market for PTCA Balloon Catheters, 2003 - 2013(US$)
- Figure 7-8 Leading Competitors, German Market for PTCA Balloon Catheters,
2006
- Figure 7-9 Units Sold, French Market for PTCA Balloon Catheters, 2003 -
2013
- Figure 7-11 French Market for PTCA Balloon Catheters, 2003 - 2013(US$)
- Figure 7-12 Leading Competitors, French Market for PTCA Balloon Catheters,
2006
- Figure 7-13 Units Sold, Italian Market for Balloon Catheters, 2003 - 2013
- Figure 7-14 Italian Market for PTCA Balloon Catheters, 2003 - 2013(€)
- Figure 7-15 Italian Market for PTCA Balloon Catheters, 2003 - 2013(US$)
- Figure 7-16 Leading Competitors, Italian Market for PTCA Balloon
Catheters, 2006
- Figure 7-17 Units Sold, U.K. Market for PTCA Balloon Catheters, 2003 - 2013
- Figure 7-18 U.K. Market for PTCA Balloon Catheters, 2003 - 2013(€)
- Figure 7-19 U.K. Market for PTCA Balloon Catheters, 2003 - 2013(US$)
- Figure 7-20 U.K. Market for PTCA Balloon Catheters, 2003 - 2013(£)
- Figure 7-21 Leading Competitors, U.K. Market for PTCA Balloon Catheters,
2006
- Figure 7-22 Units Sold, Spanish Market for PTCA Balloon Catheters, 2003 -
2013
- Figure 7-23 Spanish Market for PTCA Balloon Catheters, 2003 - 2013(€)
- Figure 7-24 Spanish Market for PTCA Balloon Catheters, 2003 - 2013(US$)
- Figure 7-25 Leading Competitors, Spanish Market for PTCA Balloon
Catheters, 2006
- Figure 7-26 Units Sold, Beneluxian Market for Balloon Catheters, 2003 -
2013
- Figure 7-27 Units Sold, Belgian Market for Balloon Catheters, 2003 - 2013
- Figure 7-28 Units Sold, Dutch Market for Balloon Catheters, 2003 - 2013
- Figure 7-29 Beneluxian Market for PTCA Balloon Catheters, 2003 -
2013(€)
- Figure 7-30 Beneluxian Market for PTCA Balloon Catheters, 2003 - 2013(US$)
- Figure 7-31 Belgian Market for PTCA Balloon Catheters, 2003 - 2013(€)
- Figure 7-32 Belgian Market for PTCA Balloon Catheters, 2003 - 2013(US$)
- Figure 7-33 Dutch Market for PTCA Balloon Catheters, 2003 - 2013(€)
- Figure 7-34 Dutch Market for PTCA Balloon Catheters, 2003 - 2013(US$)
- Figure 7-35 Leading Competitors, Beneluxian Market for PTCA Balloon
Catheters, 2006
- Figure 7-36 Units Sold, Scandinavian Market for PTCA Balloon Catheters,
2003 - 2013
- Figure 7-37 Scandinavian Market for PTCA Balloon Catheters, 2003 -
2013(€)
- Figure 7-38 Scandinavian Market for PTCA Balloon Catheters, 2003 -
2013(US$)
- Figure 7-39 Leading Competitors, Scandinavian Market for PTCA Balloon
Catheters, 2006
- Figure 7-40 Units Sold, Swiss Market for PTCA Balloon Catheters, 2003 -
2013
- Figure 7-41 Swiss Market for PTCA Balloon Catheters, 2003 - 2013(€)
- Figure 7-42 Swiss Market for PTCA Balloon Catheters, 2003 - 2013(US$)
- Figure 7-43 Swiss Market for PTCA Balloon Catheters, 2003 - 2013(SFr.)
- Figure 7-44 Leading Competitors, Swiss Market for PTCA Balloon Catheters,
2006
- Figure 7-45 Units Sold, Austrian Market for PTCA Balloon Catheters, 2003 -
2013
- Figure 7-46 Austrian Market for PTCA Balloon Catheters, 2003 - 2013(€)
- Figure 7-47 Austrian Market for PTCA Balloon Catheters, 2003 - 2013(US$)
- Figure 7-48 Leading Competitors, Austrian Market for PTCA Balloon
Catheters, 2006
- Figure 7-49 Unit Sold, Portuguese Market for PTCA Balloon Catheters, 2003
- 2013
- Figure 7-50 Portuguese Market for PTCA Balloon Catheters, 2003 -
2013(€)
- Figure 7-51 Portuguese Market for PTCA Balloon Catheters, 2003 - 2013(US$)
- Figure 7-52 Leading Competitors, Portuguese Market for PTCA Balloon
Catheters, 2006
- Figure 7-53 Units Sold, Polish Market for PTCA Balloon Catheters, 2003 -
2013
- Figure 7-54 Polish Market for PTCA Balloon Catheters, 2003 - 2013(€)
- Figure 7-55 Polish Market for PTCA Balloon Catheters, 2003 - 2013(US$)
- Figure 7-56 Polish Market for PTCA Balloon Catheters, 2003 - 2013(z1)
- Figure 7-57 Leading Competitors, Polish Market for PTCA Balloon Catheters,
2006
- Figure 8-1 European Market for Interventioanal Catheters, 2003 -
2013(€)
- Figure 8-2 European Market for Interventioanal Catheters, 2003 - 2013(US$)
- Figure 8-3 Market Drivers, European Market for Interventional Catheters,
2006
- Figure 8-4 Market Limiters, European Market for Interventional Catheters,
2006
- Figure 8-5 Leading Competitors, European Market for Interventional
Catheters, 2006
- Figure 8-6 Units Sold, German market for Interventioanal Catheters, 2003 -
2013
- Figure 8-7 German Market for Interventioanal Catheters, 2003 - 2013(€)
- Figure 8-8 German Market for Interventioanal Catheters, 2003 - 2013(US$)
- Figure 8-9 Leading Competitors, German Market for Interventional
Catheters, 2006
- Figure 8-10 Units Sold, French Market for Interventioanal Catheters, 2003
- 2013
- Figure 8-11 French Market for Interventioanal Catheters, 2003 -
2013(€)
- Figure 8-12 French Market for Interventioanal Catheters, 2003 - 2013(US$)
- Figure 8-13 Leading Competitors, French Market for Interventional
Catheters, 2006
- Figure 8-14 Units Sold, Italian Market for Interventioanal Catheters, 2003
- 2013
- Figure 8-15 Italian Market for Interventioanal Catheters, 2003 -
2013(€)
- Figure 8-16 Italian Market for Interventioanal Catheters, 2003 - 2013(US$)
- Figure 8-17 Leading Competitors, Italian Market for Interventional
Catheters, 2006
- Figure 8-18 Units Sold, U.K. Market for Interventioanal Catheters, 2003 -
2013
- Figure 8-19 U.K. Market for Interventioanal Catheters, 2003 - 2013(€)
- Figure 8-20 U.K. Market for Interventioanal Catheters, 2003 - 2013(US$)
- Figure 8-21 U.K. Market for Interventioanal Catheters, 2003 - 2013(£)
- Figure 8-22 Leading Competitors, U.K. Market for Interventional Catheters,
2006
- Figure 8-23 Units Sold, Spanish Market for Interventioanal Catheters, 2003
- 2013
- Figure 8-24 Spanish Market for Interventioanal Catheters, 2003 -
2013(€)
- Figure 8-25 Spanish Market for Interventioanal Catheters, 2003 - 2013(US$)
- Figure 8-26 Leading Competitors, Spanish Market for Interventional
Catheters, 2006
- Figure 8-27 Units Sold, Beneluxian Market for Interventioanal Catheters,
2003 - 2013
- Figure 8-28 Beneluxian Market for Interventioanal Catheters, 2003 -
2013(€)
- Figure 8-29 Beneluxian Market for Interventioanal Catheters, 2003 -
2013(US$)
- Figure 8-30 Leading Competitors, Beneluxian Market for Interventional
Catheters, 2006
- Figure 8-31 Units Sold, Scandinavian Market for Interventioanal Catheters,
2003 - 2013
- Figure 8-32 Scandinavian Market for Interventioanal Catheters, 2003 -
2013(€)
- Figure 8-33 Scandinavian Market for Interventioanal Catheters, 2003 -
2013(US$)
- Figure 8-34 Leading Competitors, Scandinavian Market for Interventional
Catheters, 2006
- Figure 8-35 Units Sold, Swiss Market for Interventioanal Catheters, 2003 -
2013
- Figure 8-36 Swiss Market for Interventioanal Catheters, 2003 - 2013(€)
- Figure 8-37 Swiss Market for Interventioanal Catheters, 2003 - 2013(US$)
- Figure 8-38 Swiss Market for Interventioanal Catheters, 2003 - 2013(SFr.)
- Figure 8-39 Leading Competitors, Swiss Market for Interventional
Catheters, 2006
- Figure 8-40 Units Sold, Austrian Market for Interventioanal Catheters,
2003 - 2013
- Figure 8-41 Austrian Market for Interventioanal Catheters, 2003 -
2013(€)
- Figure 8-42 Austrian Market for Interventioanal Catheters, 2003 - 2013(US$)
- Figure 8-43 Leading Competitors, Austrian Market for Interventional
Catheters, 2006
- Figure 8-44 Units Sold, Portuguese Market for Interventioanal Catheters,
2003 - 2013
- Figure 8-45 Portuguese Market for Interventioanal Catheters, 2003 -
2013(€)
- Figure 8-46 Portuguese Market for Interventioanal Catheters, 2003 -
2013(US$)
- Figure 8-47 Leading Competitors, Portuguese Market for Interventional
Catheters, 2006
- Figure 8-48 Units Sold, Polish Market for Interventioanal Catheters, 2003
- 2013
- Figure 8-49 Polish Market for Interventioanal Catheters, 2003 -
2013(€)
- Figure 8-50 Polish Market for Interventioanal Catheters, 2003 - 2013(US$)
- Figure 8-52 Leading Competitors, Polish Market for Interventional
Catheters, 2006
- Figure 9-1 European Market for Interventioanal Catheters, 2003 -
2013(€)
- Figure 9-2 European Market for Interventioanal Catheters, 2003 - 2013(US$)
- Figure 9-3 Market Drivers, European Market for Interventional Guidewires,
2006
- Figure 9-4 Market Limiters, European Market for Interventional Guidewires,
2006
- Figure 9-5 Leading Competitors, European Market for Interventional
Guidewires, 2006
- Figure 9-6 Units Sold, German Market for Interventional Guidewires, 2003 -
2013
- Figure 9-7 German Market for Interventional Guidewires, 2003 - 2013(€)
- Figure 9-8 German Market for Interventional Guidewires, 2003 - 2013(US$)
- Figure 9-9 Leading Competitors, German Market for Interventional
Guidewires, 2006
- Figure 9-10 Units Sold, French Market for Interventional Guidewires, 2003
- 2013
- Figure 9-11 French Market for Interventional Guidewires, 2003 -
2013(€)
- Figure 9-12 French Market for Interventional Guidewires, 2003 - 2013(US$)
- Figure 9-13 Leading Competitors, French Market for Interventional
Guidewires, 2006
- Figure 9-14 Units Sold, Italian Market for Interventional Guidewires,
2003 - 2013
- Figure 9-15 Italian Market for Interventional Guidewires, 2003 -
2013(€)
- Figure 9-16 Italian Market for Interventional Guidewires, 2003 - 2013(US$)
- Figure 9-17 Leading Competitors, Italian Market for Interventional
Guidewires, 2006
- Figure 9-18 Units Sold, U.K. Market for Interventional Guidewires, 2003 -
2013
- Figure 9-19 U.K. Market for Interventional Guidewires, 2003 - 2013(€)
- Figure 9-20 U.K. Market for Interventional Guidewires, 2003 - 2013(US$)
- Figure 9-21 U.K. Market for Interventional Guidewires, 2003 - 2013(£)
- Figure 9-22 Leading Competitors, U.K. Market for Interventional
Guidewires, 2006
- Figure 9-23 Units Sold, Spanish Market for Interventional Guidewires, 2003
- 2013(US$)
- Figure 9-24 Spanish Market for Interventional Guidewires, 2003 -
2013(€)
- Figure 9-25 Spanish Market for Interventional Guidewires, 2003 - 2013(US$)
- Figure 9-26 Leading Competitors, Spanish Market for Interventional
Guidewires, 2006
- Figure 9-27 Units Sold, Beneluxian Market for Interventional Guidewires,
2003 - 2013
- Figure 9-28 Beneluxian Market for Interventional Guidewires, 2003 -
2013(€)
- Figure 9-29 Beneluxian Market for Interventional Guidewires, 2003 -
2013(US$)
- Figure 9-30 Leading Competitors, Beneluxian Market for Interventional
Guidewires, 2006
- Figure 9-31 Units Sold, Scandinavian Market for Interventional Guidewires,
2003 - 2013
- Figure 9-32 Scandinavian Market for Interventional Guidewires, 2003 -
2013(€)
- Figure 9-33 Scandinavian Market for Interventional Guidewires, 2003 -
2013(US$)
- Figure 9-34 Leading Competitors, Scandinavian Market for Interventional
Guidewires, 2006
- Figure 9-35 Units Sold, Swiss Market for Interventional Guidewires, 2003 -
2013
- Figure 9-36 Swiss Market for Interventional Guidewires, 2003 - 2013(€)
- Figure 9-37 Swiss Market for Interventional Guidewires, 2003 - 2013(US$)
- Figure 9-38 Swiss Market for Interventional Guidewires, 2003 - 2013(SFr.)
- Figure 9-39 Leading Competitors, Swiss Market for Interventional
Guidewires, 2006
- Figure 9-40 Units Sold, Austrian Market for Interventional Guidewires,
2003 - 2013
- Figure 9-41 Austrian Market for Interventional Guidewires, 2003 -
2013(€)
- Figure 9-42 Austrian Market for Interventional Guidewires, 2003 - 2013(US$)
- Figure 9-43 Leading Competitors, Austrian Market for Interventional
Guidewires, 2006
- Figure 9-44 Units Sold, Portuguese Market for Interventional Guidewires,
2003 - 2013
- Figure 9-45 Portuguese Market for Interventional Guidewires, 2003 -
2013(€)
- Figure 9-46 Portuguese Market for Interventional Guidewires, 2003 -
2013(US$)
- Figure 9-47 Leading Competitors, Portuguese Market for Interventional
Guidewires, 2006
- Figure 9-48 Units Sold, Polish Market for Interventional Guidewires, 2003
- 2013
- Figure 9-49 Polish Market for Interventional Guidewires, 2003 -
2013(€)
- Figure 9-50 Polish Market for Interventional Guidewires, 2003 - 2013(US$)
- Figure 9-51 Polish Market for Interventional Guidewires, 2003 - 2013(z1)
- Figure 9-52 Leading Competitors, Polish Market for Interventional
Guidewires, 2006
- Figure 10-1 European Market for Introducer Sheaths, 2003 - 2013 (€)
- Figure 10-2 European Market for Introducer Sheaths, 2003 - 2013 (US$)
- Figure 10-3 European Market for Introducer Sheaths by Country 2003 - 2013
(€)
- Figure 10-4 European Market for Introducer Sheaths, by Country 2003 - 2013
(US$)
- Figure 10-5 European Market for Femoral Introducer Sheaths, 2003 - 2013
(€)
- Figure 10-6 European Market for Femoral Introducer Sheaths, 2003 - 2013
(US$)
- Figure 10-7 European Market for Transradial /Brachial Introducer Sheaths,
2003 - 2013 (€)
- Figure 10-8 European Market for Transradial /Brachial Introducer Sheaths,
2003 - 2013 (US$)
- Figure 10-9 Market Drivers and Limiters, European Market for Introducer
Sheaths, 2006
- Figure 10-10 Leading Competitors, European Market for Introducer Sheaths,
2006
- Figure 11-2 European Market for IVUS Catheters, 2003 - 2013(€)
- Figure 11-4 European Market for IVUS Catheters, 2003 - 2013(US$)
- Figure 11-5 Market Drivers, European Market for IVUS Catheters, 2006
- Figure 11-6 Market Limiters, European Market for IVUS Catheters, 2006
- Figure 11-7 Leading Competitors, European Market for IVUS Catheters, 2006
- Figure 12-1 European Market for Brachytherapy Catheters, 2003 -
2013(€)
- Figure 12-2 European Market for Brachytherapy Catheters, 2003 - 2013(US$)
- Figure 12-3 European Market for Brachytherapy Catheters, 2003 -
2013(€)
- Figure 12-4 European Market for Brachytherapy Catheters, 2003 - 2013(US$)
- Figure 12-5 Market Drivers and Limiters, European Market for Brachytherapy
Catheters, 2006
- Figure 12-6 Leading Competitors, European Market for Brachytherapy
Catheters, 2006
- Figure 13-1 European Market for Embolic Protection Devices, 2003 -
2013(€)
- Figure 13-2 European Market for Embolic Protection Devices, 2003 -
2013(US$)
- Figure 13-3 European Market for Embolic Protection Devices, 2003 -
2013(€)
- Figure 13-4 European Market for Embolic Protection Devices, 2003 - 2013
- Figure 13-5 Market Drivers and Limiters, European Market for Embolic
Protection Devices, 2006
- Figure 13-6 Leading Competitors, European Market for Embolic Protection
Devices, 2006
- Figure 14-1 European Market for Diagnostic Catheters and Guidewires by
Country, 2003 - 2013(€)
- Figure 14-2 European Market for Diagnostic Catheters and Guidewires by
Country, 2003 - 2013(US$)
- Figure 14-3 European Market for Diagnostic Catheters, 2003 - 2013(€)
- Figure 14-4 European Market for Diagnostic Catheters, 2003 - 2013(US$)
- Figure 14-5 European Market for Diagnostic Catheters, 2003 - 2013(€)
- Figure 14-6 European Market for Diagnostic Catheters, 2003 - 2013(US$)
- Figure 14-7 Market Drivers and Limiters, European Market for Diagnostic
Catheters and Guidewires, 2006
- Figure 14-8 Leading Competitors, Diagnostic Catheters and Guidewires, 2006
- Figure 15-1 Target Population, Potential European Market for Vulnerable
Plaque, 2009 - 2013
- Figure 15-2 Potential European Market for Vulnerable Plaque, Best-Case
Scenario, 2009 - 2013 (€)
- Figure 15-3 Potential European Market for Vulnerable Plaque, Best-Case
Scenario, 2009 - (US$)
- Figure 15-4 Potential European Market for Vulnerable Plaque Screening
Devices, Best-Case Senario, 2009 - 2013(€)
- Figure 15-5 Total Revenue, Potential European Market for Vulnerable Plaque
Screening Devices, Best-Case Scenario, 2009 - 2013(€)
- Figure 15-6 Potential European Market for Vulnerable Plaque Screeni ng
Devices, Best-Case Scenario, 2009 - 2013(US$)
- Figure 15-7 Total Revenue, Potential European Market for Vulnerable Plaque
Screening Devices, Best-Case Scenario, 2009 - 2013(US$)
- Figure 15-8 Potential European Market for Vulnerable Plaque Interventional
Devices, Best-Case Scenario, 2009 - 2013(US$)
- Figure 15-9 Total Revenue, Potential European Market for Vulnerable Plaque
Interventional Devices, Best-Case Scenario, 2009 - 2013(€)
- Figure 15-10 Potential European Market for Vulnerable Plaque
Interventional Best-Case Scenario, 2009 - 2013(US$)
- Figure 15-11 Total Revenue, Potential European Market for Vulnerable
Plaque Interventional Devices, Best-Case Scenario, 2009 - 2013(US$)
- Figure 15-12 Market Players, Potential European Market for Vulnerable
Plaque Devices, 2009 - 2013
LIST OF CHARTS
- Chart 1-2 Fastest Growing Interventional Cardiology Markets, Segmented by
Country, 2003 - 2013
- Chart 1-3 Angioplasty Procedures, European Market for Interventional
Cardiology, 2003 - 2013
- Chart 1-4 Portuguese Price Index , DES Penetration, Population, GDP per
Capita, and PCI Penetration Rate, 2006
- Chart 1-5 European Market for Coronary Stents by Type, 2003 - 2013 (€)
- Chart 1-6 Leading Competitors, European Market for Interventional
Cardiology, 2006
- Chart 3-2 Fastest Growing Interventional Cardiology Markets, Segmented by
Country, 2003 - 2013
- Chart 3-3 Leading Competitors, European Market for Interventional
Cardiology 2006
- Chart 3-4 Market Concentrati on based on the Herfindahl Index , European
Market for Interventional Cardiology, 2003- 2013
- Chart 4-1 Angioplasty Procedures, European Market for Interventional
Cardiology 2003 - 2013
- Chart 5-1 German Price Index , DES Penetration, Population, GDP per
Capita, and PCI Penetration Rate, 2006
- Chart 5-2 French Price Index , DES Penetration, Population, GDP per
Capita, and PCI Penetration Rate, 2006
- Chart 5-3 Italian Price Index , DES Penetration, Population, GDP per
Capita, and PCI Penetration Rate, 2006
- Chart 5-4 The U.K. Price Index , DES Penetration, Population, GDP per
Capita, and PCI Penetration Rate, 2006
- Chart 5-5 Spanish Price Index , DES Penetration, Population, GDP per
Capita, and PCI Penetration Rate, 2006
- Chart 5-6 Beneluxian Price Index , DES Penetration, Population, GDP per
Capita, and PCI Penetration Rate, 2006
- Chart 5-7 Scandinavian Price Index , DES Penetration, Population, GDP per
Capita, and PCI Penetration Rate, 2006
- Chart 5-8 Swiss Price Index , DES Penetration, Population, GDP per Capita,
and PCI Penetration Rate, 2006
- Chart 5-9 Austrian Price Index , DES Penetration, Population, GDP per
Capita, and PCI Penetration Rate, 2006
- Chart 5-10 Portuguese Price Index , DES Penetration, Population, GDP per
Capita, and PCI Penetration Rate, 2006
- Chart 5-11 Polish Price Index , DES Penetration, Population, GDP per
Capita, and PCI Penetration Rate, 2006
- Chart 6-1 European Market for Coronary Stents by Type, 2003 - 2013 (€)
- Chart 6-2 European Penetration Rate for Coronary Stents by Type, Units
Sold, 2003 - 2013
- Chart 6-3 Penetration Rate by Country, European Market for Drug-Eluting
Stents, 2006 - 2007
- Chart 6-4 BMS Penetration Rate in Germany, 2003 - 2013
- Chart 6-5 DES Penetration Rate in Germany, 2003 - 2013
- Chart 6-6 BMS Penetration Rate in France, 2003 - 2013
- Chart 6-7 DES Penetration Rate in France, 2003 - 2013
- Chart 6-8 BMS Penetration Rate in Italy, 2003 - 2013
- Chart 6-9 DES Penetration Rate in Italy, 2003 - 2013
- Chart 6-10 BMS Penetraion Rate in United Kingdom, 2003 - 2013
- Chart 6-11 DES Penetraion Rate in United Kingdom, 2003 - 2013
- Chart 6-12 BMS Penetraion Rate in Spain, 2003 - 2013
- Chart 6-13 DES Penetraion Rate in Spain, 2003 - 2013
- Chart 6-14 Beneluzian Market for Coronary Stents by Type, 2003 - 2013
- Chart 6-15 BMS Penetraion Rate in Benelux, 2003 - 2013
- Chart 6-16 DES Penetration Rate in Benelux, 2003 - 2013
- Chart 6-17 BMS Penetration Rate in Scandinavia, 2003 - 2013
- Chart 6-18 DES Penetration Rate in Scandinavia, 2003 - 2013
- Chart 6-19 BMS Penetration Rate in Switzerland, 2003 - 2013
- Chart 6-20 DES Penetration Rate in Switzerland, 2003 - 2013
- Chart 6-21 BMS Penetration Rate in Austria, 2003 - 2013
- Chart 6-22 DES Penetration Rate in Austria, 2003 - 2013
- Chart 6-23 BMS Penetration Rate in Portugal, 2003 - 2013
- Chart 6-24 DES Penetration Rate in Portugal, 2003 - 2013
- Chart 6-25 BMS Penetration Rate in Poland, 2003 - 2013
- Chart 6-26 DES Penetration Rate in Poland, 2003 - 2013
- Chart 7-1 European Market for PTCA Balloon Catheters, 2003 - 2013(€)
- Chart 8-1 European Market Interventional Catheters, 2003 - 2013 (€)
- Chart 9-1 European Market Interventional Guidewires, 2003 - 2013 (€)
- Chart 13-1 European Market for Embolic Protection Devices, 2003 - 2013
- Chart 14-1 European Market for Diagnostic Catheters and Guidewires, 2003 -
2013
- Chart 14-2 European Market for Diagnostic Catheters, 2003 - 2013
- Chart 14-3 European Market for Diagnostic Guidewires, 2003 - 2013
- Chart 15-1 Potential European Market for Vulnerable Plaque, Best-Case
Scenario, 2009
- Chart 15-2 Total Revenue Probability, Potential European Market for
Vulnerable Plaque Devices (Screening and Interconventional), 2009 - 2013
|
Related Report
|
View Cart
